Design Therapeutics spikes as RBC upgrades on an eventful 2026
Source: SeekingAlpha
2025-11-20 11:57:19 ET
More on Design Therapeutics
- Design Therapeutics, Inc. (DSGN) Presents at Cantor Global Healthcare Conference 2025 Transcript
- Design Therapeutics GAAP EPS of -$0.30 beats by $0.04
- Seeking Alpha’s Quant Rating on Design Therapeutics
- Historical earnings data for Design Therapeutics
- Financial information for Design Therapeutics
Read the full article on Seeking Alpha
For further details see:
Design Therapeutics spikes as RBC upgrades on an eventful 2026
Design Therapeutics Inc.
NASDAQ: DSGN
DSGN Trading
3.77% G/L:
$10.33 Last:
75,392 Volume:
$9.93 Open:
DSGN Latest News
March 09, 2026 04:01:00 pm
Design Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Updates
DSGN Stock Data
$582,169,597
25,405,836
1.78%
33
N/A
Biotechnology & Life Sciences
Healthcare
US
Carlsbad
